Pfizer CEO Says Covid Is ‘Irrelevant.’ He’s Betting on Cancer and Weight-Loss Drugs.
Pfizer CEO downplays COVID-19, betting on cancer and weight-loss drugs
10 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 10 separate news trends connected to Pfizer, spanning June 23, 2026 through November 3, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 89 article observations and 85 source signals, led by Business, Health coverage. Use it to compare how individual events emerged, spread and changed over time.
Pfizer CEO downplays COVID-19, betting on cancer and weight-loss drugs
Pfizer’s 2026 profit outlook jumps as new drugs eclipse waning Covid sales, sparking fresh market optimism.
Vaxcyte's stock soars 36% as pneumococcal vaccine shows promise against Pfizer and Merck.
25 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
The FDA has approved new Covid vaccines, but the companies that make them are already talking about availability.
5 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
Pfizer's Covid pill revenue has dropped 95%, driving a shift in the company's financial strategy.
4 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
Nike has appointed former Pfizer executive David Denton as its new CFO during a period of strategic turnaround.
Pfizer's Phase 3 trial for the lung cancer drug Sigvotatug Vedotin failed to meet its primary endpoint for survival.